Aarhus University Seal / Aarhus Universitets segl

Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Mette Richner
  • Lone T Pallesen
  • Maj Ulrichsen, The Lundbeck Foundation Research Center MIND, Department of Biomedicine, Aarhus University, Aarhus, 8000 C, Denmark.
  • ,
  • Ebbe T Poulsen
  • ,
  • Thomas H Holm
  • ,
  • Hande Login
  • Annie Castonguay, Department of Psychiatry and Neuroscience, Université Laval, Québec, QC, Canada.
  • ,
  • Louis-Etienne Lorenzo, Department of Psychiatry and Neuroscience, Université Laval, Québec, QC, Canada.
  • ,
  • Nádia P Gonçalves
  • Olav M Andersen
  • Karin Lykke-Hartmann
  • Jan J Enghild
  • Lars C B Rønn, Neurodegeneration Disease Biology Unit, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark.
  • ,
  • Ibrahim J Malik, Neurodegeneration Disease Biology Unit, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark.
  • ,
  • Yves De Koninck, Department of Psychiatry and Neuroscience, Université Laval, Québec, QC, Canada.
  • ,
  • Ole J Bjerrum, Department of Drug Design and Pharmacology, University of Copenhagen, Denmark
  • ,
  • Christian B Vægter
  • Anders Nykjær

Neuropathic pain is a major incurable clinical problem resulting from peripheral nerve trauma or disease. A central mechanism is the reduced expression of the potassium chloride cotransporter 2 (KCC2) in dorsal horn neurons induced by brain-derived neurotrophic factor (BDNF), causing neuronal disinhibition within spinal nociceptive pathways. Here, we demonstrate how neurotensin receptor 2 (NTSR2) signaling impairs BDNF-induced spinal KCC2 down-regulation, showing how these two pathways converge to control the abnormal sensory response following peripheral nerve injury. We establish how sortilin regulates this convergence by scavenging neurotensin from binding to NTSR2, thus modulating its inhibitory effect on BDNF-mediated mechanical allodynia. Using sortilin-deficient mice or receptor inhibition by antibodies or a small-molecule antagonist, we lastly demonstrate that we are able to fully block BDNF-induced pain and alleviate injury-induced neuropathic pain, validating sortilin as a clinically relevant target.

Original languageEnglish
Article numbereaav9946
JournalScience Advances
Volume5
Issue6
Number of pages13
ISSN2375-2548
DOIs
Publication statusPublished - 19 Jun 2019

    Research areas

  • ANION GRADIENT, BRAIN, IDENTIFICATION, INTERNALIZATION, MAINTENANCE, MESSENGER-RNA, NERVE INJURY, PROTEIN, RECEPTOR, SPINAL-CORD

See relations at Aarhus University Citationformats

ID: 157139667